Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates
COLLCollegium Pharmaceutical(COLL) ZACKS·2024-08-09 06:25

Collegium Pharmaceutical (COLL) came out with quarterly earnings of 1.62pershare,beatingtheZacksConsensusEstimateof1.62 per share, beating the Zacks Consensus Estimate of 1.56 per share. This compares to earnings of 1.26pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof3.851.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.85%. A quarter ago, it was expected that this specialty pharmaceutical company would post earnings of 1.49 per share when it actually produced earnings of $1.45, delivering a surprise of -2.68%.Over the ...